PUBLISHER: The Business Research Company | PRODUCT CODE: 2111427
PUBLISHER: The Business Research Company | PRODUCT CODE: 2111427
Generative artificial intelligence (AI) for clinical documentation refers to AI systems that automatically create, summarize, and structure clinical notes from doctor-patient interactions, reducing manual paperwork. It helps healthcare providers improve accuracy, save time, and enhance patient care by integrating with EHR systems and automating documentation workflows.
The primary component types of generative artificial intelligence (AI) for clinical documentation include solutions and services. Solutions refer to AI-powered platforms and software designed to automate and enhance clinical documentation workflows within healthcare systems. These are deployed through cloud-based, on-premises, and hybrid environments. The various applications include clinical note generation, chart summarization, referral letter and documentation drafting, and they are utilized by end-users including hospitals or ambulatory surgery centers and specialty clinics.
Tariffs are influencing the generative artificial intelligence (AI) for clinical documentation market by increasing the cost of imported servers, graphics processing units, cloud infrastructure hardware, and semiconductor-based components required to run large language model-driven documentation systems. This is slowing deployment of advanced clinical documentation solutions, particularly in cloud-based and on-premises healthcare IT environments across import-dependent regions such as Asia-Pacific and Latin America. Hardware-intensive segments including AI medical scribing platforms and ambient clinical documentation software are most affected due to supply chain disruptions and higher procurement costs. However, tariffs are also driving localization of hardware manufacturing, strengthening regional cloud ecosystems, and encouraging healthcare providers and vendors to invest in domestic AI infrastructure, which may improve long-term supply chain resilience and innovation capacity.
The generative artificial intelligence (AI) for clinical documentation market size has grown exponentially in recent years. It will grow from $0.83 billion in 2025 to $1.11 billion in 2026 at a compound annual growth rate (CAGR) of 34.6%. The growth in the historic period can be attributed to growing adoption of electronic health records systems, increasing administrative burden on healthcare providers, rising physician shortage and workforce constraints, expanding healthcare digital transformation initiatives, increasing demand for structured and accurate patient data management.
The generative artificial intelligence (AI) for clinical documentation market size is expected to see exponential growth in the next few years. It will grow to $3.6 billion in 2030 at a compound annual growth rate (CAGR) of 34.1%. The growth in the forecast period can be attributed to advancing generative artificial intelligence capabilities in healthcare, increasing investment in healthcare automation and digital health infrastructure, growing demand for real-time clinical decision support tools, expanding shift toward value based care models, rising focus on reducing operational and documentation costs in healthcare systems. Major trends in the forecast period include increasing adoption of ambient clinical documentation software, growing integration of speech-to-text documentation systems in healthcare workflows, rising demand for automated clinical note generation to reduce physician burnout, expanding use of AI-assisted chart summarization for faster clinical decision making, increasing focus on interoperability between clinical documentation platforms and electronic health records systems.
The growing adoption of telehealth is expected to propel the growth of the generative artificial intelligence (AI) for clinical documentation market going forward. Telehealth refers to the delivery of healthcare services through digital communication technologies that enable remote consultation, diagnosis, monitoring, and treatment of patients. The increasing adoption of telehealth is driven by rising demand for convenient healthcare access and the reduced need for in-person hospital visits, particularly in rural and underserved regions. Generative artificial intelligence (AI) for clinical documentation supports telehealth by automatically generating structured clinical notes from virtual patient-physician interactions, reducing physician administrative workload, improving documentation accuracy, and enhancing workflow efficiency in remote care settings. For instance, in April 2023, FAIR Health Inc., a US-based non-profit organization, reported a 7.3% national increase in telehealth usage, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the growing adoption of telehealth is driving the growth of the generative artificial intelligence (AI) for clinical documentation market.
Major companies operating in the generative artificial intelligence (AI) for clinical documentation market are focusing on integrating generative AI documentation tools, such as ambient clinical documentation systems, to improve physician productivity, reduce administrative burden, and enhance clinical workflow efficiency. Ambient clinical documentation systems refer to AI-powered solutions that capture clinician-patient conversations in real time and automatically convert them into structured medical notes within electronic health record systems. For instance, in September 2023, Microsoft Corporation, a US-based technology company, launched DAX Copilot within its Nuance healthcare portfolio. The solution provides real-time ambient listening, automated clinical note generation, and deep integration with electronic health record systems. It also includes specialty-specific documentation templates, voice-enabled workflow automation, and AI-assisted clinical summarization to reduce physician documentation workload.
In July 2024, Commure Inc., a US-based healthcare AI infrastructure and clinical workflow automation company, merged with Augmedix Inc. for approximately $139 million. Through this merger, Commure Inc. aimed to strengthen its generative AI for clinical documentation capabilities by integrating Augmedix Inc.'s ambient AI medical scribing technology into its enterprise healthcare platform, enabling more scalable, real-time physician documentation automation and reducing administrative burden across clinical environments. Augmedix Inc. is a US-based company specializing in generative AI solutions and services for clinical documentation.
Major companies operating in the generative artificial intelligence (AI) for clinical documentation market are Microsoft Corporation; Amazon.com Inc.; Alphabet Inc.; Oracle Corporation; Epic Systems Corporation; Medical Information Technology Inc.; Solventum Corporation; Abridge AI Inc.; DeepScribe Inc.; Commure Inc.; Suki AI Inc.; Freed AI; Nym Health; Veradigm LLC; Notable Health Inc.; CorroHealth Inc.; Ambience Healthcare Inc.; John Snow Labs Inc.; Augmedix Inc.; Corti ApS; Nabla Technologies SAS; Tali AI Inc.; DeepCura; Mutuo Health Solutions
North America was the largest region in the generative artificial intelligence (AI) for clinical documentation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) for clinical documentation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the generative artificial intelligence (AI) for clinical documentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The generative artificial intelligence (AI) for clinical documentation market consists of revenues earned by entities by providing services such as automated medical transcription, electronic health record (EHR) documentation support, clinical workflow automation, medical coding assistance, and clinical decision support integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) for clinical documentation market also includes sales of AI-enabled digital stethoscopes, medical speech recognition microphones, ambient clinical listening devices, and smart examination room sensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The generative artificial intelligence (AI) for clinical documentation market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) for clinical documentation market statistics, including generative artificial intelligence (AI) for clinical documentation industry global market size, regional shares, competitors with a generative artificial intelligence (AI) for clinical documentation market share, detailed generative artificial intelligence (AI) for clinical documentation market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) for clinical documentation industry. This generative artificial intelligence (AI) for clinical documentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Generative Artificial Intelligence (AI) For Clinical Documentation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses generative artificial intelligence (ai) for clinical documentation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for generative artificial intelligence (ai) for clinical documentation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The generative artificial intelligence (ai) for clinical documentation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.